David M. Berman, HEAD OF R&D at Immunocore Holdings plc (IMCR), sold 99,638 shares at $36.12 ($3.6M) on 2025-09-10, disclosed to the SEC on 2025-09-12.
Scheduled sale ($3.6M) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.12 | 30,138 | $1.1M | 30.2% |
| 2 | $36.12 | 30,138 | $1.1M | 30.2% |
| 3 | $36.77 | 1,200 | $44K | 1.2% |
| 4 | $36.28 | 19,081 | $692K | 19.2% |
| 5 | $36.28 | 19,081 | $692K | 19.2% |
| Total | $36.19 avg | 99,638 |
| $3.6M |
| 100% |
| Filing → |
| IMCR | SELL | 2025-12-01 | $6.0M | — | Filing → |
| IMCR | SELL | 2025-11-26 | $1.4M | — | Filing → |
| IMCR | SELL | 2025-10-02 | $4.4M | — | Filing → |